Literature DB >> 27059696

Evidence of response to IL-6 inhibition in some cases of refractory spondyloarthritis-associated peripheral synovitis.

Mira Merashli1, Gabriele De Marco1, Mark Podgorski2, Dennis McGonagle1, Helena Marzo-Ortega1.   

Abstract

Entities:  

Keywords:  Ankylosing Spondylitis; Cytokines; Spondyloarthritis

Mesh:

Substances:

Year:  2016        PMID: 27059696     DOI: 10.1136/annrheumdis-2016-209275

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  Transforming clinical trials in rheumatology: towards patient-centric precision medicine.

Authors:  Costantino Pitzalis; Ernest H S Choy; Maya H Buch
Journal:  Nat Rev Rheumatol       Date:  2020-09-04       Impact factor: 20.543

Review 2.  New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice.

Authors:  Sayam Dubash; Dennis McGonagle; Helena Marzo-Ortega
Journal:  Ther Adv Chronic Dis       Date:  2017-12-14       Impact factor: 5.091

3.  Integration of Immunome With Disease-Gene Network Reveals Common Cellular Mechanisms Between IMIDs and Drug Repurposing Strategies.

Authors:  Abhinandan Devaprasad; Timothy R D J Radstake; Aridaman Pandit
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

4.  Genetic Associations Between IL-6 and the Development of Autoimmune Arthritis Are Gender-Specific.

Authors:  Jianqiao Hong; Zihao Qu; Xiaoxiao Ji; Congsun Li; Geng Zhang; Ciliang Jin; Jie Wang; Yongxing Zhang; Yue Shen; Jiahong Meng; Chenhe Zhou; Chaohua Fang; Wei Wang; Shigui Yan
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

Review 5.  Monocytes and Macrophages in Spondyloarthritis: Functional Roles and Effects of Current Therapies.

Authors:  Sara Martínez-Ramos; Carlos Rafael-Vidal; José M Pego-Reigosa; Samuel García
Journal:  Cells       Date:  2022-02-02       Impact factor: 6.600

6.  A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment.

Authors:  M Filippini; S Cartella; O Bonzanini; E Morello; A Tincani
Journal:  Case Rep Rheumatol       Date:  2018-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.